|1.||Respiratory Tract Infections (Respiratory Tract Infection)
11/01/1997 - "In vitro and in vivo antibacterial activities of CS-940, a new fluoroquinolone, against isolates from patients with respiratory infections."
11/01/1997 - "aureus, CS-940 was as active as tosufloxacin, with a MIC90 of 16 microg/ml. The efficacy of CS-940 against murine respiratory infections due to S. "
|2.||Bacterial Infections (Bacterial Infection)